Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hala H, Shamsuddin"'
Autor:
Matthew G. Johnson, Julie M. Strizki, Michelle L. Brown, Hong Wan, Hala H. Shamsuddin, Moti Ramgopal, Diana F. Florescu, Pierre Delobel, Ilsiyar Khaertynova, José F. Flores, Leon F. Fouche, Shan-Chwen Chang, Angela Williams-Diaz, Jiejun Du, Jay A. Grobler, Amanda Paschke, Carisa De Anda
Publikováno v:
Infection.
Purpose Immunocompromised patients have a potentially increased risk for progression to severe COVID-19 and prolonged replication of SARS-CoV-2. This post hoc analysis examined outcomes among immunocompromised participants in the MOVe-OUT trial. Meth
Autor:
Angélica, Jayk Bernal, Monica M, Gomes da Silva, Dany B, Musungaie, Evgeniy, Kovalchuk, Antonio, Gonzalez, Virginia, Delos Reyes, Alejandro, Martín-Quirós, Yoseph, Caraco, Angela, Williams-Diaz, Michelle L, Brown, Jiejun, Du, Alison, Pedley, Christopher, Assaid, Julie, Strizki, Jay A, Grobler, Hala H, Shamsuddin, Robert, Tipping, Hong, Wan, Amanda, Paschke, Joan R, Butterton, Matthew G, Johnson, Carisa, De Anda, Mary Beth, Graham
Publikováno v:
The New England journal of medicine. 386(6)
New treatments are needed to reduce the risk of progression of coronavirus disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).We condu
Autor:
Chelsea Lam, Marsha E. Reichman, Jeffrey A. Kelman, Sumathi Nambiar, Monika Houstoun, Thomas E. MaCurdy, S. Christopher Jones, Chris Worrall, Michael Wernecke, Hala H. Shamsuddin, David J. Graham, Kelly Y. Cao
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:911-917
Purpose In 2005, the Food and Drug Administration approved Qualaquin (quinine) for treatment of malaria and later ordered unapproved quinine formulations off the market. In 2009, labeling for Qualaquin added a warning for use for leg cramps, as serio
Autor:
Leonard Sacks, Michael Lanthier, Rachel E. Sherman, Hala H. Shamsuddin, Khaled Bouri, Yuliya Yasinskaya
Publikováno v:
JAMA. 311(4)
Importance Some new drug applications fail because of inadequate drug performance and others are not approved because the information submitted to the US Food and Drug Administration (FDA) is unsatisfactory to make that determination. Resubmission of
Autor:
Shamsuddin H, Raudenbush CL, Sciba BL, Zhou YP, Mast TC; Pharmaco-epidemiology., Greaves WL; Global Clinical Development, Merck Sharp & Dohme Corp., North Wales, PA., Hanna GJ; Global Clinical Development, Merck Sharp & Dohme Corp., North Wales, PA., Leong R, Straus W
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2019 Jul 01; Vol. 81 (3), pp. 247-250.
Autor:
Houstoun M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Reichman ME, Graham DJ, Nambiar S, Shamsuddin H, Jones SC, Cao K, Wernecke M, Lam C, Worrall CM, MaCurdy TE, Kelman JA
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2014 Sep; Vol. 23 (9), pp. 911-7. Date of Electronic Publication: 2014 May 28.
Autor:
Johannsson B; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. birgir-johannsson@uiowa.edu, Taylor J, Clark CR, Shamsuddin H, Beekmann SE, Polgreen P
Publikováno v:
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2010 Jan; Vol. 66 (1), pp. 16-23. Date of Electronic Publication: 2009 Sep 25.
Autor:
Mollano AV; Department of Orthopaedics and Rehabilitation, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52246, USA. anthony-mollano@uiowa.edu, Shamsuddin H, Suh JS
Publikováno v:
The Iowa orthopaedic journal [Iowa Orthop J] 2005; Vol. 25, pp. 53-6.
Autor:
Ross JJ; From Division of Infectious Diseases (JJR), Caritas Saint Elizabeth's Medical Center, Boston, Massachusetts, and Division of Infectious Diseases (HS), University of Iowa Hospitals, Iowa City, Iowa., Shamsuddin H
Publikováno v:
Medicine [Medicine (Baltimore)] 2004 May; Vol. 83 (3), pp. 139-148.